ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

CNTG Centogene NV

0.4406
0.0066 (1.52%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Centogene NV CNTG 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0066 1.52% 0.4406 13:00:02
개장가 저가 고가 종가 전일 종가
0.438 0.43 0.4557 0.442851 0.434
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/04/202405:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
19/03/202419:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
01/03/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/03/202407:00GLOBECENTOGENE Collaborates on Research Published in Science..
28/02/202420:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/02/202420:30GLOBECENTOGENE Announces Receipt of Nasdaq Notice of Delisting..
28/02/202420:30GLOBECENTOGENE Explores Strategic Alternatives
28/02/202420:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/01/202420:30GLOBECENTOGENE and the Laboratory of Human Genetics of Infectious..
25/01/202420:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/01/202420:30GLOBECENTOGENE Receives French Research Tax Credit Accreditation
24/01/202420:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/01/202420:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/01/202420:30GLOBECENTOGENE and The Michael J. Fox Foundation Announce..
18/01/202421:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/01/202420:30GLOBECENTOGENE Announces Preliminary Full Year 2023 Revenue
19/12/202321:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202320:30GLOBECENTOGENE Announces Voting Results of Extraordinary General..
18/12/202320:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202320:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202320:30GLOBECENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study,..
01/12/202320:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202320:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
28/11/202320:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202322:30GLOBECENTOGENE, University College London, and Global Team of..
04/11/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202320:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202319:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202319:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
07/10/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202321:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
08/09/202306:00GLOBECENTOGENE Reports First Half 2023 Financial Results
08/09/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/09/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/09/202321:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
01/09/202305:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
01/09/202305:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/08/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/08/202319:30GLOBECENTOGENE to Participate in Upcoming Conferences in August
14/07/202319:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/07/202319:30GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
12/07/202320:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/07/202320:30GLOBECENTOGENE Biodatabank Reveals Unique Genetic Variants in..
02/07/202318:00PRNUSLifera and CENTOGENE, Enter Strategic Collaboration -..
01/07/202305:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/07/202305:30GLOBECENTOGENE Announces Approval of All Resolutions Tabled at..
27/06/202320:30GLOBECENTOGENE and Lifera, a Biopharma Company Owned by the PIF,..
15/06/202305:30GLOBECENTOGENE Receives Nasdaq Notification Regarding Minimum..
17/05/202307:25GLOBECENTOGENE Reports Full Year 2022 Financial Results

최근 히스토리

Delayed Upgrade Clock